4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-21-063798
Chief Executive Officer bought 4,500 shares at $3.50 ($15,750)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schambye Hans T. Chief Executive Officer | 2021-11-09 | Purchase | +4,500 | $3.50 | $15,750 | 47,428 | D |
| Open-market purchases · 4,500 sh · avg $3.50 · $15,750 | |||||||
Loading xslF345X03/doc4.xml…